Sugimoto Tadafumi, Mizuno Atsushi, Yoneoka Daisuke, Matsumoto Shingo, Matsumoto Chisa, Matsue Yuya, Ishida Mari, Nakai Michikazu, Iwanaga Yoshitaka, Miyamoto Yoshihiro, Node Koichi
Department of Cardiology and Nephrology, Mie University Graduate School of Medicine Tsu Japan.
Information and Communication Committee, the Japanese Circulation Society Tokyo Japan.
Circ Rep. 2022 Jul 1;4(8):353-362. doi: 10.1253/circrep.CR-22-0058. eCollection 2022 Aug 10.
Although reductions in hospitalizations for myocardial infarction and heart failure have been reported during the period of COVID-19 pandemic restrictions, it is unclear how the overall number of hospitalizations for cardiovascular disease (CVD) treatment changed in the early stages of the pandemic. We analyzed the records of 574 certified hospitals affiliated with the Japanese Circulation Society and retrieved data from April 2015 to March 2020. Records were obtained from the nationwide Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination database. A quasi-Poisson regression model was used to estimate the number of hospitalizations for CVD treatment. Between January and March 2020, when the number of COVID-19 cases was relatively low in Japan, the actual/estimated number of hospitalizations for acute CVD was 18,233/21,634 (84.3%), whereas the actual/estimated number of scheduled hospitalizations was 16,921/19,066 (88.7%). The number of hospitalizations for acute heart failure and scheduled hospitalizations for valvular disease and aortic aneurysm were 81.1%, 84.6%, and 83.8% of the estimated values, respectively. A subanalysis that considered only facilities without hospitalization restrictions did not alter the results for these diseases. The spread of COVID-19 was associated with a decreased number of hospitalizations for CVD in Japan, even in the early stages of the pandemic.
尽管有报告称在新冠疫情限制期间心肌梗死和心力衰竭的住院人数有所减少，但尚不清楚在疫情早期心血管疾病（CVD）治疗的总体住院人数发生了怎样的变化。我们分析了日本循环学会下属574家认证医院的记录，并检索了2015年4月至2020年3月的数据。记录来自日本全国性的所有心脏和血管疾病诊断程序组合数据库。采用准泊松回归模型来估计CVD治疗的住院人数。在2020年1月至3月期间，日本的新冠病例数相对较少，急性CVD的实际/估计住院人数为18,233/21,634（84.3%），而计划性住院的实际/估计人数为16,921/19,066（88.7%）。急性心力衰竭的住院人数以及瓣膜病和主动脉瘤计划性住院人数分别为估计值的81.1%、84.6%和83.8%。仅考虑无住院限制设施的亚分析并未改变这些疾病的结果。即使在疫情早期，新冠疫情的传播也与日本CVD住院人数的减少有关。
